Adenosine A2AR blockade prevents neuroinflammation-induced death of retinal ganglion cells caused by elevated pressure
暂无分享,去创建一个
R. Cunha | A. Ambrósio | A. R. Santiago | F. Gonçalves | F. Elvas | M. Madeira | R. Boia
[1] S. Lewandowsky. PLOS ONE 2013 , 2015 .
[2] Â. R. Tomé,et al. ATP as a multi-target danger signal in the brain , 2015, Front. Neurosci..
[3] B. Lin,et al. Fractalkine receptor regulates microglial neurotoxicity in an experimental mouse glaucoma model , 2014, Glia.
[4] V. Sheffield,et al. Mechanosensitive release of adenosine 5′‐triphosphate through pannexin channels and mechanosensitive upregulation of pannexin channels in optic nerve head astrocytes: A mechanism for purinergic involvement in chronic strain , 2014, Glia.
[5] Francis Loth,et al. Systemic inflammation regulates microglial responses to tissue damage in vivo , 2014, Glia.
[6] R. Cunha,et al. Role of Microglia Adenosine A2A Receptors in Retinal and Brain Neurodegenerative Diseases , 2014, Mediators of inflammation.
[7] Rosa M. Ferrer-Martín,et al. Microglial cells in organotypic cultures of developing and adult mouse retina and their relationship with cell death. , 2014, Experimental eye research.
[8] N. Tian,et al. From Mechanosensitivity to Inflammatory Responses: New Players in the Pathology of Glaucoma , 2014, Current eye research.
[9] J. Caprioli. Glaucoma: a disease of early cellular senescence. , 2013, Investigative ophthalmology & visual science.
[10] J. Gonzales,et al. Potential role of A2A adenosine receptor in traumatic optic neuropathy , 2013, Journal of Neuroimmunology.
[11] S. Takai,et al. P2X7 receptor activation may be involved in neuronal loss in the retinal ganglion cell layer after acute elevation of intraocular pressure in rats , 2013, Molecular vision.
[12] C. Métin,et al. Adenosine Receptor Antagonists Including Caffeine Alter Fetal Brain Development in Mice , 2013, Science Translational Medicine.
[13] S. Koizumi,et al. Microglia release ATP by exocytosis , 2013, Glia.
[14] C. Müller,et al. Ecto-5′-Nucleotidase (CD73)-Mediated Formation of Adenosine Is Critical for the Striatal Adenosine A2A Receptor Functions , 2013, The Journal of Neuroscience.
[15] V. Porciatti,et al. A new mouse model of inducible, chronic retinal ganglion cell dysfunction not associated with cell death. , 2013, Investigative ophthalmology & visual science.
[16] D. Broadway,et al. P2X7 receptor activation mediates retinal ganglion cell death in a human retina model of ischemic neurodegeneration. , 2013, Investigative ophthalmology & visual science.
[17] N. Pfeiffer,et al. Enhanced Insight into the Autoimmune Component of Glaucoma: IgG Autoantibody Accumulation and Pro-Inflammatory Conditions in Human Glaucomatous Retina , 2013, PloS one.
[18] Catarina Gomes,et al. Activation of microglial cells triggers a release of brain-derived neurotrophic factor (BDNF) inducing their proliferation in an adenosine A2A receptor-dependent manner: A2A receptor blockade prevents BDNF release and proliferation of microglia , 2013, Journal of Neuroinflammation.
[19] J. Filosa,et al. A quantitative spatiotemporal analysis of microglia morphology during ischemic stroke and reperfusion , 2013, Journal of Neuroinflammation.
[20] Â. R. Tomé,et al. Blockade of adenosine A2A receptors prevents interleukin-1β-induced exacerbation of neuronal toxicity through a p38 mitogen-activated protein kinase pathway , 2012, Journal of Neuroinflammation.
[21] N. Pfeiffer,et al. Retinal Ganglion Cell Loss Is Accompanied by Antibody Depositions and Increased Levels of Microglia after Immunization with Retinal Antigens , 2012, PloS one.
[22] A. Laties,et al. Neurons respond directly to mechanical deformation with pannexin‐mediated ATP release and autostimulation of P2X7 receptors , 2012, The Journal of physiology.
[23] Joan W. Miller,et al. Etanercept, a Widely Used Inhibitor of Tumor Necrosis Factor-α (TNF- α), Prevents Retinal Ganglion Cell Loss in a Rat Model of Glaucoma , 2012, PloS one.
[24] L. Levin,et al. Clinical evidence for neuroprotection in glaucoma. , 2011, American journal of ophthalmology.
[25] A. Laties,et al. Sustained elevation of extracellular ATP in aqueous humor from humans with primary chronic angle-closure glaucoma. , 2011, Experimental eye research.
[26] K. Cho,et al. Glial cell response and iNOS expression in the optic nerve head and retina of the rat following acute high IOP ischemia–reperfusion , 2011, Brain Research.
[27] A. Kraft,et al. Features of Microglia and Neuroinflammation Relevant to Environmental Exposure and Neurotoxicity , 2011, International journal of environmental research and public health.
[28] C. Luu,et al. Retinal ganglion cell death is induced by microglia derived pro‐inflammatory cytokines in the hypoxic neonatal retina , 2011, The Journal of pathology.
[29] K. Martin,et al. Use of an adult rat retinal explant model for screening of potential retinal ganglion cell neuroprotective therapies. , 2011, Investigative ophthalmology & visual science.
[30] Catarina Gomes,et al. Adenosine receptors and brain diseases: neuroprotection and neurodegeneration. , 2011, Biochimica et biophysica acta.
[31] J. T. Erichsen,et al. Involvement of the CD200 receptor complex in microglia activation in experimental glaucoma. , 2011, Experimental eye research.
[32] R. Caldwell,et al. A(₂A) adenosine receptor (A(₂A)AR) as a therapeutic target in diabetic retinopathy. , 2011, The American journal of pathology.
[33] H. Kettenmann,et al. Physiology of microglia. , 2011, Physiological reviews.
[34] Matthew A. Hibbs,et al. Molecular clustering identifies complement and endothelin induction as early events in a mouse model of glaucoma. , 2011, The Journal of clinical investigation.
[35] M. Lynch,et al. Adenosine A2A receptors control neuroinflammation and consequent hippocampal neuronal dysfunction , 2011, Journal of neurochemistry.
[36] M. Vidal-Sanz,et al. Brain derived neurotrophic factor maintains Brn3a expression in axotomized rat retinal ganglion cells. , 2011, Experimental eye research.
[37] B. Fredholm,et al. International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors—An Update , 2011, Pharmacological Reviews.
[38] M. Vetter,et al. Early microglia activation in a mouse model of chronic glaucoma , 2011, The Journal of comparative neurology.
[39] G. Liou,et al. Retinal Microglial Activation and Inflammation Induced by Amadori-Glycated Albumin in a Rat Model of Diabetes , 2011, Diabetes.
[40] J. Mallol,et al. Gi protein coupling to adenosine A1–A2A receptor heteromers in human brain caudate nucleus , 2010, Journal of neurochemistry.
[41] Yan Zhao,et al. Local Glutamate Level Dictates Adenosine A2A Receptor Regulation of Neuroinflammation and Traumatic Brain Injury , 2010, The Journal of Neuroscience.
[42] O. Gavet,et al. Progressive activation of CyclinB1-Cdk1 coordinates entry to mitosis. , 2010, Developmental cell.
[43] R. Cunha,et al. Adenosine A2A Receptor Blockade Prevents Synaptotoxicity and Memory Dysfunction Caused by β-Amyloid Peptides via p38 Mitogen-Activated Protein Kinase Pathway , 2009, The Journal of Neuroscience.
[44] W. Kamphuis,et al. Diabetes changes the levels of ionotropic glutamate receptors in the rat retina , 2009, Molecular vision.
[45] M. Vidal-Sanz,et al. Brn3a as a marker of retinal ganglion cells: qualitative and quantitative time course studies in naive and optic nerve-injured retinas. , 2009, Investigative ophthalmology & visual science.
[46] C. Mitchell,et al. Elevated pressure triggers a physiological release of ATP from the retina: Possible role for pannexin hemichannels , 2008, Neuroscience.
[47] K. Martin,et al. Development and characterization of an adult retinal explant organotypic tissue culture system as an in vitro intraocular stem cell transplantation model. , 2008, Investigative ophthalmology & visual science.
[48] K. Jacobson,et al. Stimulation of the P2X7 receptor kills rat retinal ganglion cells in vivo. , 2010, Experimental eye research.
[49] David J. Calkins,et al. Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucoma. , 2008, Investigative ophthalmology & visual science.
[50] Wei Li,et al. Chronic but not acute treatment with caffeine attenuates traumatic brain injury in the mouse cortical impact model , 2008, Neuroscience.
[51] R. Cunha,et al. Adenosine A2A Receptors Are Essential for Long-Term Potentiation of NMDA-EPSCs at Hippocampal Mossy Fiber Synapses , 2008, Neuron.
[52] G. Brown. Mechanisms of inflammatory neurodegeneration: iNOS and NADPH oxidase. , 2007, Biochemical Society transactions.
[53] A. Laties,et al. Acute increase of intraocular pressure releases ATP into the anterior chamber. , 2007, Experimental eye research.
[54] R. Cunha,et al. Blockade of adenosine A2A receptors prevents staurosporine-induced apoptosis of rat hippocampal neurons , 2007, Neurobiology of Disease.
[55] D. Blum,et al. Effects of the Adenosine A2A Receptor Antagonist SCH 58621 on Cyclooxygenase-2 Expression, Glial Activation, and Brain-Derived Neurotrophic Factor Availability in a Rat Model of Striatal Neurodegeneration , 2007, Journal of neuropathology and experimental neurology.
[56] F. Di Virgilio,et al. Acute retinal ganglion cell injury caused by intraocular pressure spikes is mediated by endogenous extracellular ATP , 2007, The European journal of neuroscience.
[57] David J. Calkins,et al. Pressure-induced regulation of IL-6 in retinal glial cells: involvement of the ubiquitin/proteasome pathway and NFkappaB. , 2006, Investigative ophthalmology & visual science.
[58] Pál Pacher,et al. Adenosine receptors: therapeutic aspects for inflammatory and immune diseases , 2006, Nature Reviews Drug Discovery.
[59] David J. Calkins,et al. Interleukin-6 protects retinal ganglion cells from pressure-induced death. , 2006, Investigative ophthalmology & visual science.
[60] M. Dailey,et al. Early activation, motility, and homing of neonatal microglia to injured neurons does not require protein synthesis , 2006, Glia.
[61] R. Moratalla,et al. Adenosine A2A receptor stimulation potentiates nitric oxide release by activated microglia , 2005, Journal of neurochemistry.
[62] R. Cunha,et al. Different roles of adenosine A1, A2A and A3 receptors in controlling kainate-induced toxicity in cortical cultured neurons , 2005, Neurochemistry International.
[63] R. Cunha,et al. Neuroprotection by adenosine in the brain: From A1 receptor activation to A2A receptor blockade , 2005, Purinergic Signalling.
[64] S. Resnikoff,et al. Global data on visual impairment in the year 2002. , 2004, Bulletin of the World Health Organization.
[65] B. Fredholm,et al. Binding of adenosine receptor ligands to brain of adenosine receptor knock-out mice: evidence that CGS 21680 binds to A1 receptors in hippocampus , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.
[66] Claus Lindbjerg Andersen,et al. Normalization of Real-Time Quantitative Reverse Transcription-PCR Data: A Model-Based Variance Estimation Approach to Identify Genes Suited for Normalization, Applied to Bladder and Colon Cancer Data Sets , 2004, Cancer Research.
[67] S. Isenmann,et al. A novel primary culture technique for adult retina allows for evaluation of CNS axon regeneration in rodents , 2004, Journal of Neuroscience Methods.
[68] Manfred Thiel,et al. Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. , 2004, Annual review of immunology.
[69] S. Schiffmann,et al. A Dual Role of Adenosine A2A Receptors in 3-Nitropropionic Acid-Induced Striatal Lesions: Implications for the Neuroprotective Potential of A2A Antagonists , 2003, The Journal of Neuroscience.
[70] Eric A Newman,et al. Glial Cell Inhibition of Neurons by Release of ATP , 2003, The Journal of Neuroscience.
[71] S. Thanos,et al. Detection of early neuron degeneration and accompanying microglial responses in the retina of a rat model of glaucoma. , 2002, Investigative ophthalmology & visual science.
[72] Lin Wang,et al. Immunohistologic evidence for retinal glial cell changes in human glaucoma. , 2002, Investigative ophthalmology & visual science.
[73] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[74] H. Hara,et al. Interleukin-1β mediates ischemic injury in the rat retina , 2001 .
[75] R. Stone,et al. A1‐, A2A‐ and A3‐subtype adenosine receptors modulate intraocular pressure in the mouse , 2001, British journal of pharmacology.
[76] M. Wax,et al. TNF-alpha and TNF-alpha receptor-1 in the retina of normal and glaucomatous eyes. , 2001, Investigative ophthalmology & visual science.
[77] R. Paes-de-Carvalho,et al. Long-term activation of adenosine A2a receptors blocks glutamate excitotoxicity in cultures of avian retinal neurons , 2001, Brain Research.
[78] M. Wax,et al. Increased Production of Tumor Necrosis Factor-a by Glial Cells Exposed to Simulated Ischemia or Elevated Hydrostatic Pressure Induces Apoptosis in Cocultured Retinal Ganglion Cells , 2000 .
[79] R. Cunha,et al. Modification by Arachidonic Acid of Extracellular Adenosine Metabolism and Neuromodulatory Action in the Rat Hippocampus* , 2000, The Journal of Biological Chemistry.
[80] A. Neufeld,et al. Tumor necrosis factor‐α: A potentially neurodestructive cytokine produced by glia in the human glaucomatous optic nerve head , 2000 .
[81] A. Neufeld. Microglia in the optic nerve head and the region of parapapillary chorioretinal atrophy in glaucoma. , 1999, Archives of ophthalmology.
[82] A. Engel,et al. PloS One 2012 , 2015 .
[83] R. Cunha,et al. Blockade of adenosine A(2A) receptors prevents staurosporine-induced apoptosis of rat hippocampal neurons. , 2007, Neurobiology of disease.
[84] M. Parravano,et al. Interleukin-1beta tear concentration in glaucomatous and ocular hypertensive patients treated with preservative-free nonselective beta-blockers. , 2005, American journal of ophthalmology.
[85] H. Hara,et al. Interleukin-1beta mediates ischemic injury in the rat retina. , 2001, Experimental eye research.
[86] M. Wax,et al. TNF-a and TNF-a Receptor-1 in the Retina of Normal and Glaucomatous Eyes , 2001 .